0
Skip to Content
Vital Biomedical
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Vital Biomedical
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Folder: HOME
Back
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Katie Coffee 11/19/26 Katie Coffee 11/19/26

Boston Scientific's Obsidio embolic occluded all target vessels in 125-patient U.S. registry

Boston Scientific's Obsidio embolic occluded 100% of target vessels in the 125-patient OCCLUDE registry; the FDA approves Infilbray for type 3 Gaucher disease and Livsayis, the first siRNA therapy for myasthenia gravis.

Read More
Katie Coffee 11/14/26 Katie Coffee 11/14/26

U.S. reported to lose measles elimination status after 26 years

The U.S. is reported to have lost its measles elimination status after 26 years; CMS lets states delay Medicaid work-requirement enforcement to mid-2027 and the FDA approves a new bladder cancer regimen.

Read More
Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Subscribe

Sign up with your email address to receive news and updates.

We respect your privacy.

Thank you!

© 2026 Vital Biomedical News. Content is for informational purposes only and is not medical advice. About · Contact